Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Urgn Stock Analysis Urogen Pharma Ltd. Ordinary Shares Dips 0.63 To Hold 18.82 Price Level 20260403 Anix Q1 2026 Earnings Anixa Biosciences Beats Eps Ests Posts No Revenue 20260403 1 Is Mdxhealth Sa Mdxh Stock A Market Leader Price At 2.13 Down 1.39 20260406 Is Sound Sfbc Stock Expanding Price At 41.95 Down 0.17 20260406 Is Netflix Nflx Stock Trending Down Price At 98.57 Down 0.09 20260406 TCOM Tripcom Group Limited American Depositary Shares posts 48 percent Q4 2025 EPS surprise shares rise 091 percent after earnings release UMB UMBF Stock Breakout Watch In Focus 20260418 Affiliated MGR Stock Success Guide Bullish Sentiment 20260415 Why MFS MFM is a smarter play than most realize 018 20260508 Tompkins TMP beats Q1 earnings estimates by 28 yet stock slides 157 in cautious market response FuboTV FUBO Stock Valuation Gap Analysis Q1 2026 EPS Beats Forecasts Dollar General Corporation DG AI Monetization Push Governance Risks and the Evolving Operational Efficiency Narrative How to Manage Microbot Medical MBOT Stock Risk Modest Decline 20260420 The edge Martin MLM has in a competitive landscape Investor Interest 20260511 Vanguard Group VOO Comparative Analysis of Vanguard Growth ETFs VOOG vs VUG for LongTerm Portfolio Allocation Micron Technology Inc MU AI Memory Supercycle Drives Compelling Bullish Investment Thesis SLXN Silexion Therapeutics posts wider than expected Q4 2025 loss pushing shares 301 percent lower in todays trading JHG Janus reports 72 percent upside to consensus EPS for Q4 2025 shares trade flat today The fundamentals driving Calamos Conv CHI everyone should understand Slight Gain 20260506 Dodgers Former Catcher Signs with CrossTown Rival After Brief Tenure Tata Trusts Challenges Charity Commissioners Directive to Postpone Board Meeting Amid Trustee Amendment Dispute SP 500 Poised to Cross 8000 Prediction Market Traders Signal Over 50 Probability Republic RJET Earnings Outlook Key Metrics for Q1 2026 National Restaurant Association Research Highlights GDP Impact on Restaurant Industry Monro MNRO Falls 292 Watching 1452 Support 20260519 Buda Juice BUDA Holds 930 Direction Awaited 20260518 electroCore ECOR Stock Down 249 Support Test at 596 20260517 Seabridge SA Q1 2024 Earnings Revenue NA Matching Views X Corp Fined A650000 for NonCompliance with Australian Child Protection Laws Quanex Building Products NX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline XP Inc Q1 2026 Earnings Call Highlights Strategic Focus and Market Position Bitcoin Consolidates as Equity Markets Rally in Weekly Trading Session Citius Pharmaceuticals CTXR A Penny Stock Option Among Wall Street Analyst Favorites ECB Signals No Urgency to Address Market Expectations of June Rate Move Retail Investors Reduce Stakes in Reliance Industries TCS HDFC Bank and Other Major Stocks in Q4 Labor Market Cooling What Markets Expect from Aprils Jobs Report COCH Q1 2026 Earnings Narrower Loss Beats Estimates as Envoy Medical Advances FOXF Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Challenges Value Line Inc Q1 2026 Earnings EPS of 069 Surprises Despite Revenue Silence Stifel Q1 2026 Earnings Modest EPS Beat Amid Market Challenges Shares Edge Lower BOOM Q1 2026 Earnings Surprising EPS Beat Despite Challenging Environment NextTrip Inc NTRP Rallies 348 as Stock Tests Key Resistance at 250 Organon Co OGN Holds Steady Near Support as Market Digests Flat Trading Session Quanterix QTRX Rallies 189 as Shares Test Key Resistance Near 282 ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573 Asbury Auto ABG Peer Comparison Asbury Automotive Group Inc posts 09 EPS miss Deere Company DE AgTech Transformation Driving Agricultural Technology Investment Opportunities IPSC Century Therapeutics Inc posts narrower Q4 2025 loss than expected shares gain 656 percent in daily trading What Global GIC management said that matters most Q1 2026 Below Expectations ABUS Arbutus Biopharma Corporation beats fourth quarter 2025 earnings estimates shares rise nearly three percent on soaring year over year revenue